TME Pharma N.V. (ALTME) — Cash Flow-to-Debt Ratio
TME Pharma N.V. (ALTME) has a Cash Flow-to-Debt Ratio of -0.15x as of December 2025, meaning its operating cash flow of €-557.00K could theoretically repay 0% of its total liabilities (€3.72 Million) in one year. Explore ALTME long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
TME Pharma N.V. Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for TME Pharma N.V. across 12 annual periods. Also explore TME Pharma N.V. (ALTME) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for TME Pharma N.V. (2014–2025)
Year-by-year debt coverage analysis for TME Pharma N.V.. For market capitalisation and broader financial context, see ALTME market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.92x | €-3.42 Million | €3.72 Million | ▲ +64.5% |
| 2024 | -2.59x | €-4.63 Million | €1.79 Million | ▼ -27.8% |
| 2023 | -2.02x | €-5.63 Million | €2.79 Million | ▼ -8.5% |
| 2022 | -1.86x | €-12.14 Million | €6.51 Million | ▲ +20.7% |
| 2021 | -2.35x | €-12.38 Million | €5.27 Million | ▼ -33.0% |
| 2020 | -1.77x | €-5.22 Million | €2.96 Million | ▼ -47.9% |
| 2019 | -1.20x | €-4.29 Million | €3.59 Million | ▼ -112.9% |
| 2018 | -0.56x | €-4.00 Million | €7.12 Million | ▲ +35.8% |
| 2017 | -0.87x | €-4.24 Million | €4.85 Million | ▲ +48.0% |
| 2016 | -1.68x | €-8.99 Million | €5.35 Million | ▼ -62.9% |
| 2015 | -1.03x | €-13.48 Million | €13.07 Million | ▲ +22.7% |
| 2014 | -1.33x | €-12.46 Million | €9.33 Million | — |